These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 17302610

  • 1. Nature of cell kinetics in psoriatic epidermis.
    Doger FK, Dikicioglu E, Ergin F, Unal E, Sendur N, Uslu M.
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of cell death and proliferation in psoriatic epidermis.
    Kawashima K, Doi H, Ito Y, Shibata MA, Yoshinaka R, Otsuki Y.
    J Dermatol Sci; 2004 Sep; 35(3):207-14. PubMed ID: 15381242
    [Abstract] [Full Text] [Related]

  • 3. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
    Yang J, Li Y, Liu YQ, Long JW, Tian F, Dong J, Shen GX, Tu YT, Tao J.
    Eur J Dermatol; 2009 Sep; 19(1):29-33. PubMed ID: 19059832
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
    Abdou AG, Hanout HM.
    J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis in psoriatic epidermis.
    Heenen M, Simonart T.
    J Cutan Pathol; 2008 Mar; 35(3):346. PubMed ID: 18251754
    [No Abstract] [Full Text] [Related]

  • 6. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
    Tatlican S, Arikok A, Gulbahar O, Eren C, Cevirgen B, Eskioglu F.
    J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
    [Abstract] [Full Text] [Related]

  • 7. Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasis.
    Fukuya Y, Higaki M, Higaki Y, Kawashima M.
    Arch Dermatol Res; 2002 Feb; 293(12):620-5. PubMed ID: 11875645
    [Abstract] [Full Text] [Related]

  • 8. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T.
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [Abstract] [Full Text] [Related]

  • 9. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
    Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca AD, Krüger-Krasagakis S.
    Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
    [Abstract] [Full Text] [Related]

  • 10. Examination of bcl-2 and p53 expressions and apoptotic index by TUNEL method in psoriasis.
    Gündüz K, Demireli P, Vatansever S, Inanir I.
    J Cutan Pathol; 2006 Dec; 33(12):788-92. PubMed ID: 17177938
    [Abstract] [Full Text] [Related]

  • 11. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY, Kraan MC, Teunissen MB, Picavet DI, de Rie MA, Bos JD, Tak PP.
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [Abstract] [Full Text] [Related]

  • 12. The combination of the Zenon labeling technique and microscopic image analysis to study cell populations in normal and psoriatic epidermis.
    van Duijnhoven MW, van de Kerkhof PC, Pasch MC, Muys L, van Erp PE.
    J Cutan Pathol; 2005 Mar; 32(3):212-9. PubMed ID: 15701083
    [Abstract] [Full Text] [Related]

  • 13. Expression of Bcl-2 family proteins in psoriasis.
    Batinac T, Zamolo G, Hadzisejdić I, Zauhar G, Brumini G, Ruzić A, Persić V.
    Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
    [Abstract] [Full Text] [Related]

  • 14. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
    Adişen E, Gülekon A, Erdem O, Dursun A, Gürer MA.
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
    [Abstract] [Full Text] [Related]

  • 15. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ, Seyger MM, Van de Kerkhof PC.
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis.
    El-Domyati M, Barakat M, Abdel-Razek R, El-Din Anbar T.
    Int J Dermatol; 2007 May; 46(5):468-74. PubMed ID: 17472673
    [Abstract] [Full Text] [Related]

  • 17. Heat shock proteins 60 and 70 expression of cutaneous lichen planus: comparison with normal skin and psoriasis vulgaris.
    Bayramgürler D, Ozkara SK, Apaydin R, Erçin C, Bilen N.
    J Cutan Pathol; 2004 Oct; 31(9):586-94. PubMed ID: 15330989
    [Abstract] [Full Text] [Related]

  • 18. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T, Nishioka K.
    Skin Pharmacol Appl Skin Physiol; 2003 Oct; 16(1):50-8. PubMed ID: 12566829
    [Abstract] [Full Text] [Related]

  • 19. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE, van Duijnhoven MW, Pasch MC, van Erp PE, van de Kerkhof PC.
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [Abstract] [Full Text] [Related]

  • 20. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
    van Lingen RG, Poll MK, Seyger MM, de Jong EM, van de Kerkhof PC, van Erp PE.
    Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.